BridgeBio Pharma, Inc. · NASDAQ:BBIO

BlackRock, Inc. reported a 5.10% stake in BridgeBio Pharma, Inc. (Schedule 13G)

Event Sep 30, 2026 · Filed Oct 27, 2026

BlackRock, Inc. reported a 5.10% stake in BridgeBio Pharma, Inc., 9,892,226 shares, as a passive investor on Sep 30, 2026. Filed Oct 27, 2026 (Schedule 13G).

Stake
5.10%
Shares
9,892,226
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.10%9,892,226

Source

Download original · View original at SEC

Related